Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Opthea Limited Sponsored ADR ( (OPT) ) just unveiled an update.
Opthea Limited reported its financial results for the year ended June 30, 2025, showing a significant increase in revenues by 57.9% compared to the previous year. Despite a net loss of $162.8 million, the loss decreased by 26% from the prior year. The company’s major expenditures were related to research and development, especially costs associated with Phase 3 clinical trials for sozinibercept in wet AMD, which were ultimately terminated due to negative outcomes. The company also received an R&D tax incentive payment, contributing to its financial performance. No dividends were declared or paid during the reporting period.
The most recent analyst rating on (OPT) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Opthea Limited Sponsored ADR stock, see the OPT Stock Forecast page.
Spark’s Take on OPT Stock
According to Spark, TipRanks’ AI Analyst, OPT is a Underperform.
Opthea Limited’s stock is currently rated low due to significant financial challenges, including persistent losses, high leverage, and poor cash flow management. The technical analysis indicates a bearish trend with no immediate recovery signals. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, suggesting limited appeal to investors seeking growth or income. The stock’s high beta adds to the risk profile, emphasizing the need for strategic improvements to enhance financial performance.
To see Spark’s full report on OPT stock, click here.
More about Opthea Limited Sponsored ADR
Opthea Limited is a biotechnology company based in Australia, primarily focusing on the development of therapies for eye diseases. The company is engaged in research and development, particularly in advancing treatments for wet age-related macular degeneration (AMD).
Technical Sentiment Signal: Sell
Current Market Cap: $483.2M
For an in-depth examination of OPT stock, go to TipRanks’ Overview page.